M&A

News

Novartis has agreed to buy Anthos from private equity firm Blackstone for $3.1 billion, taking Factor XI inhibitor abelacimab back in-house.

News

Merck KGaA has acknowledged that it is in talks to buy US cancer SpringWorks, but cautioned there is no guarantee a deal will be forthcoming.

News

It's been 10 years since Roche bought InterMune for $8.3bn on the promise of its pulmonary fibrosis drug Esbriet. Now, it's sold the business.

News

Bain Capital has agreed to buy Mitsubishi Tanabe for around $3.4 bn, setting up one of the largest private equity buyouts in Japan's health sector.

News

Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England.

News

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.